[Argyrophilic grain disease].
Togo
Takashi
T
Department of Psychiatry, Yokohama City University School of Medicine.
Iseki
Eizo
E
D000483:Alleles; D014150:Antipsychotic Agents / Q000627:therapeutic use; D053327:Apolipoprotein E4; D001057:Apolipoproteins E / Q000235:genetics; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003704:Dementia / Q000175:diagnosis / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D006239:Haplotypes; D006624:Hippocampus / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D018895:Microsatellite Repeats; D012307:Risk Factors; D016622:Silver Staining; D016875:tau Proteins / Q000235:genetics / Q000378:metabolism
D014150:Antipsychotic Agents; D053327:Apolipoprotein E4; D001057:Apolipoproteins E; D002800:Cholinesterase Inhibitors; D016875:tau Proteins